BlackRock »

Gt Biopharma shares owned by BlackRock

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $23k 9.7k 2.31

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Gt Biopharma

DekaBank Deutsche Girozentrale
Geode Capital Management
Vanguard Group
Susquehanna International
Wells Fargo & Company
BlackRock
BlackRock
Tower Research Capital
Morgan Stanley
Bank of America Corporation
Advisor Group Holdings
Blue Bell Private Wealth Management
Bnp Paribas Arbitrage, Snc
Royal Bank of Canada
Jpmorgan Chase & Co

View all funds holding Gt Biopharma